Sun Pharma Loses Trademark

The Supreme Court has made a decision in the trademark dispute between *Sun Pharma* and *Intas*. The case is about a prescription medicine that can only be sold with a prescription from a registered medical practitioner. This type of medicine is called a Schedule H drug under India's *Drugs and Cosmetics Rules*.
- The dispute is about *trademark* infringement.
- The court's decision is important for the pharmaceutical industry in India.
- It shows how important it is to follow regulations and respect *intellectual property* rights.
The court's decision has significant implications for the pharmaceutical industry in India, as it emphasizes the need for companies to adhere to regulations and respect the intellectual property rights of others.